Stimulation of electrogenic glucose transport by glycogen synthase kinase 3

Cellular Physiology and Biochemistry

Volumn 26, Issue 4-5, 2010, Pages 641-646

  Rexhepaj, Rexhep ^a   Dërmaku Sopjani, Miribane ^a   Gehring, Eva Maria ^a   Sopjani, Mentor ^a   Kempe, Daniela S ^a   Föller, Michael ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dual electrode voltage clamp; Intestine; SGLT1; Ussing chamber

Indexed keywords

ALANINE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM ION;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRIC CURRENT; ELECTRODE; ELECTROGENIC GLUCOSE TRANSPORT; FEMALE; GENE MUTATION; GENE TARGETING; GLUCOSE TRANSPORT; IMMUNOHISTOCHEMISTRY; INTESTINE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SODIUM CURRENT; SODIUM TRANSPORT; STIMULATION; VOLTAGE CLAMP; WILD TYPE; XENOPUS;

MUS;

EID: 78149444465     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322331     Document Type: Article

References (28)

1. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2001;2:769-776.
2. Cole AR, Sutherland C: Measuring GSK3 expression and activity in cells. Methods Mol Biol 2008;468:45-65.
3. Wada A: GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics. Front Biosci 2009;14:1558-1570.
4. Giese KP: GSK-3: a key player in neurodegeneration and memory. IUBMB Life 2009;61:516-521.
5. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ: Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009;104:1240-1252.
6. Cross HR, Radda GK, Clarke K: The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study. Magn Reson Med 1995;34:673-685.
7. Mora A, Sakamoto K, McManus EJ, Alessi DR: Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS Lett 2005;579:3632-3638.
8. Shaw M, Cohen P, Alessi DR: Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphor-ylation of Ser-9 and not by dephosphor-ylation of Tyr-216. FEBS Lett 1997;416:307-311.
9. Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T: Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 2003;278:25802-25807.
10. Wyatt AW, Hussain A, Amann K, Klingel K, Kandolf R, Artunc F, Grahammer F, Huang DY, Vallon V, Kuhl D, Lang F: DOCA-induced phosphorylation of gly-cogen synthase kinase 3beta. Cell Physiol Biochem 2006;17:137-144.
11. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR: Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 2005;24:1571-1583.
12. Boini KM, Bhandaru M, Mack A, Lang F: Steroid hormone release as well as renal water and electrolyte excretion of mice expressing PKB/SGK-resistant GSK3. Pflugers Arch 2008;456:1207-1216.
13. Boini KM, Amann K, Kempe D, Alessi DR, Lang F: Proteinuria in mice expressing PKB/SGK-resistant GSK3. Am J Physiol Renal Physiol 2009;296:F153-F159.
14. Dieter M, Palmada M, Rajamanickam J, Aydin A, Busjahn A, Boehmer C, Luft FC, Lang F: Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes Res 2004;12:862-870.
15. Wright EM, Hirayama BA, Loo DF: Active sugar transport in health and disease. J Intern Med 2007;261:32-43.
16. Grahammer F, Henke G, Sandu C, Rexhepaj R, Hussain A, Friedrich B, Risler T, Metzger M, Just L, Skutella T, Wulff P, Kuhl D, Lang F: Intestinal function of gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1. Am J Physiol Gastrointest Liver Physiol 2006;290:G1114-G1123.
17. Sandu C, Rexhepaj R, Grahammer F, McCormick JA, Henke G, Palmada M, Nammi S, Lang U, Metzger M, Just L, Skutella T, Dawson K, Wang J, Pearce D, Lang F: Decreased intestinal glucose transport in the sgk3-knockout mouse. Pflugers Arch 2005;451:437-444.
18. Boehmer C, Laufer J, Jeyaraj S, Klaus F, Lindner R, Lang F, Palmada M: Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cell Physiol Biochem 2008;22:591-600.
19. Henrion U, Strutz-Seebohm N, Duszenko M, Lang F, Seebohm G: Long QT syndrome-associated mutations in the voltage sensor of I(Ks) channels. Cell Physiol Biochem 2009;24:11-16.
20. Boehmer C, Palmada M, Klaus F, Jeyaraj S, Lindner R, Laufer J, Daniel H, Lang F: The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2. Cell Physiol Biochem 2008;22:705-714.
21. Laufer J, Boehmer C, Jeyaraj S, Knuwer M, Klaus F, Lindner R, Palmada M, Lang F: The C-terminal PDZ-binding motif in the Kv1.5 potassium channel governs its modulation by the Na+/H+ exchanger regulatory factor 2. Cell Physiol Biochem 2009;23:25-36.
22. Gehring EM, Zurn A, Klaus F, Laufer J, Sopjani M, Lindner R, Strutz-Seebohm N, Tavare JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F: Regulation of the glutamate transporter EAAT2 by PIKfyve. Cell Physiol Biochem 2009;24:361-368.
23. Ishiki M, Klip A: Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 2005;146:5071-5078.
24. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V: (Patho)physiological significance of the serum- and glucocorticoid-inducible ki-nase isoforms. Physiol Rev 2006;86:1151-1178.
25. Pedersen SF: The Na+/H+ exchanger NHE1 in stress-induced signal transduc-tion: implications for cell proliferation and cell death. Pflugers Arch 2006;452:249-259.
26. Plas DR, Thompson CB: Akt-dependent transformation: there is more to growth than just surviving. Oncogene 2005;24:7435-7442.
27. Cohen P, Goedert M: GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 2004;3:479-487.
28. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T: Transgenic mice overexpressing gly-cogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006;26:9022-9029.